Murphy & Mullick Capital Management’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding IDNA
WBG
Murphy & Mullick Capital Management's IDNA Position: Q3 2026 in Review
Murphy & Mullick Capital Management held its iShares Genomics Immunology and Healthcare ETF (IDNA) position steady in Q3 2026 at 275 shares worth $11.6K. The position accounts for 0.01% of the portfolio, ranked #482.
Murphy & Mullick Capital Management first reported a position in IDNA in Q4 2024 and has held it in 8 quarters since. 81 funds tracked by Wall St. Rank hold IDNA as of Q3 2026.
- Murphy & Mullick Capital Management held 275 shares of iShares Genomics Immunology and Healthcare ETF worth $11.6K as of Q3 2026.
- Murphy & Mullick Capital Management left its iShares Genomics Immunology and Healthcare ETF share count unchanged in Q3 2026.
- iShares Genomics Immunology and Healthcare ETF made up 0.01% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #482 holding.
- Murphy & Mullick Capital Management first reported a position in iShares Genomics Immunology and Healthcare ETF in Q4 2024 and has held it in 8 quarters since.
- 81 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2026.
Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.